RHJA
OFIX icon

Rice Hall James & Associates’s Orthofix Medical OFIX Stock Holding History

Rice Hall James & Associates’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,869
Closed -$1.38M – 279
2019
Q4 		$1.38M Sell
29,869
-308
-1% -$14.5K 0.05% 211
2019
Q3 		$1.6M Buy
+30,177
New +$1.56M 0.06% 198

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Rice Hall James & Associates's OFIX Position: Q1 2020 in Review

Rice Hall James & Associates sold out of Orthofix Medical (OFIX) in Q1 2020, closing a stake of 29,869 shares — an estimated $1.38M sold.

Rice Hall James & Associates first reported a position in OFIX in Q3 2019 and held it in 2 quarters. The position peaked at $1.6M in Q3 2019. 145 funds tracked by Wall St. Rank hold OFIX as of Q1 2020.

  • Rice Hall James & Associates reported no remaining Orthofix Medical position as of Q1 2020 after selling out during the quarter.
  • Rice Hall James & Associates sold 29,869 Orthofix Medical shares in Q1 2020, an estimated $1.38M.
  • Rice Hall James & Associates first reported a position in Orthofix Medical in Q3 2019 and held it in 2 quarters.
  • Rice Hall James & Associates's Orthofix Medical position peaked at $1.6M in Q3 2019.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2020.

Based on Rice Hall James & Associates's 13F filing for Q1 2020, filed 15 May 2020.